Type of Posting: Revision Bulletin
Posting Date: 27–Aug–2010
Official Date: 01–Oct–2010
Expert Committee: Monographs—Small Molecules 3
In accordance with the Rules and Procedures of the 2010–2015 Council of Experts, the Monographs—Small Molecules 3 Expert Committee has revised the Oxaliplatin for Injection monograph. The purpose for the revision is to accommodate the sponsor's FDA-approved specifications for Assay, Organic impurities, pH and Water.
The Oxaliplatin for Injection Revision Bulletin supersedes the currently official monograph and will be incorporated in the First Supplement to USP 34–NF 29.
Should you have any questions, please contact Feiwen Mao, M.S. (301-816-8320 or fm@usp.org).